← FDA DRUG APPROVALS

FDA ANDA · ANDA086213

CHLORDIAZEPOXIDE HYDROCHLORIDE

Sponsor: IMPAX LABS

APPLICATION
ANDA086213
TYPE
ANDA
ORIGINAL APPROVAL
1979-07-10
LATEST ACTION
1992-01-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CHLORDIAZEPOXIDE HYDROCHLORIDEDiscontinued
CHLORDIAZEPOXIDE HYDROCHLORIDE 5MG · CAPSULE · ORAL

Approval history

1992-01-10Labeling · Supplement 6AP
1991-10-09Labeling · Supplement 5AP
1991-09-17Labeling · Supplement 4AP
1991-02-04Labeling · Supplement 3AP
1991-02-04Labeling · Supplement 2AP
1989-10-24Labeling · Supplement 1AP
1979-07-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →